This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
A new intracellular drugdelivery centre will be established in the UK to support potential ribonucleic acid (RNA) vaccines and therapeutics , as well as the development of innovative drugdelivery technologies. Another key focus area will be the creation of a framework to develop advanced nano-delivery systems.
In the last three years alone, there have been over 633,000 patents filed and granted in the pharmaceutical industry, according to GlobalData’s report on Key innovation: Leading companies in nanoparticles for drugdelivery. Bristol-Myers Squibb is the leading patent filer in nanoparticles for drugdelivery.
The successful launch of mRNA vaccines during the Covid-19 pandemic has not only spurred mRNA-related research across interdisciplinary groups, but also further validated the use of lipid nanoparticles as delivery approaches.
Interest in the pulmonary route has also grown in recent years because delivering the drugs through the lungs allows direct systemic delivery and bypasses the first pass metabolism. Why is pulmonary drugdelivery a complex challenge? How can we accomplish drugdelivery to the lungs in nonclinical studies?
Proceeds from the IPO will fund preclinical and clinical development for Polyrizon’s innovative hydrogel product candidates, supporting further research and development (R&D). Polyrizon’s focus on intranasal protection aligns with a rapidly expanding market in drugdelivery innovation. Polyrizon Ltd.
A REVIEW OF MAGNETIC NANOPARTICLES IN TARGETED DRUGDELIVERY admin Mon, 05/29/2023 - 15:04 About Authors CHETNA MODI 1 *, VINIT MODI 2 , SHWETA RAY 2 , PIYUSH NARIYA 2 , VARSHA GADHVI 2 1 Professor, Department of Pharmaceutics, Anand Pharmacy College, Anand, Gujarat, India. chetnamodi306@gmail.com
at Northwestern University—has developed novel technology with the potential to change the future of drugdelivery. A team of scientists—led by Yamin Zhang, Ph.D., and Colin Franz, MD, Ph.D., at Shirley Ryan AbilityLab and John Rogers, Ph.D.,
The next time you need to take a prescription drug, taking it might be as easy as putting on a contact lens, thanks to a new discovery made by University of Waterloo researchers.
Treating diseases such as Alzheimer’s or Parkinson’s is a challenge because drugs have to be able to cross the blood–brain barrier. To solve this issue, the postdoctoral researcher Jean-Michel Rabanel, […].
Researchers at the University of Toronto see a future where a single injection under the eyelid could replace months of daily eye drops to treat glaucoma, a leading cause of blindness.
Hence, a precision therapy or we can say a target therapy (involving intracellular drugdelivery) is much needed to all the patients suffering from cancer. Here is how the intracellular drugdelivery comes into action for majority of the fatal diseases that requires target therapy. The answer is yes.
Similarly, the target delivery approach in healthcare would take the drugs directly to right where it’s needed: the disease site, icing apt treatment. We have put in our best effort to make it easily graspable what are the intracellular drugdelivery technologies and how it can ensure effective treatment for fatal disease.
Biologics constitute a majority of the top selling drugs and represent one of the fastest growing segments of the overall pharmaceutical industry. Our Social Media Platform Web: [link] LinkedIn: [link] Twitter: [link] The post Subcutaneous Medications and DrugDelivery Systems appeared first on Blog.
— University of Louisville researchers have found a less toxic way to deliver medicines by using the natural lipids in plants, particularly grapefruit and ginger. Suite of technologies now has commercial partner to bring them to market Credit: University of Louisville LOUISVILLE, Ky.
Innovations in Formulation and Device Design for Enhanced Subcutaneous Delivery. As Part of Europe’s leading Injectable conference series, we will assess innovations in drug product formulation and biologics, new technologies in device design and the use of long-release injectable compounds. reaching £915 billion by 2027.
It has combined expertise in otology, gene therapy and inner ear drugdelivery to meet the requirements of individuals with disabling hearing loss globally. Akouos focuses on developing adeno-associated viral gene therapies to treat inner ear conditions, including sensorineural hearing loss.
According to Precedence Research, the global injectable drugdelivery market reached U.S. Simplifying the administration of complex injectables for reconstitution, liquid/liquid mixing and the sequential delivery of multiple liquid drugs.
Furthermore, a wide variety of drugs and macromolecules, including DNA , proteins, and imaging agents, can be encapsulated in liposomal vesicles due to their unique ability to entrap both lipophilic and hydrophilic substances. The various therapeutic applications of liposomes in drugdelivery have been highlighted in the figure.
Interestingly, over the past few years, drug developers focused on non-respiratory diseases have also shifted their attention towards intranasal drug formulations. This can be attributed to ease of delivery, increased bioavailability and by-pass of first-pass metabolism offered by this type of route of administration.
Sorrento Technologies, a biotech firm developing novel treatments for COVID-19 and aggressive cancers such as melanoma, has received FDA clearance to start a research collaboration together with Mayo Clinic.
North America DrugDelivery Market Research Report 2021 with Forecasts to 2026 – ResearchAndMarkets.com North America DrugDelivery Market Research Report 2021 with Forecasts to 2026 – ResearchAndMarkets.com DUBLIN–(BUSINESS WIRE)–The “North America DrugDelivery Market – Forecasts from 2021 to … Continue reading (..)
Federally funded study says drugdelivery for certain common eye diseases could be improved Credit: University of Cincinnati Getting poked in the eye with a sharp object is a cringeworthy thought.
World Leading DrugDeliveryResearcher Professor Ryan Donnelly Joins PharmaTher as Scientific and Technical Advisor World Leading DrugDeliveryResearcher Professor Ryan Donnelly Joins PharmaTher as Scientific and Technical Advisor Focus on expanding the delivery of controlled-substances in a microneedle … Continue reading →
The drugdelivery platform company is exploring the viability of remdesivir and other potential treatments for the virus using its DehydraTECH technology.
The repurposing of FDA-approved drugs for alternative diseases is a faster way of bringing new treatments into the clinic. Researchers at Karolinska Institutet in Sweden have repurposed a cancer drug for treatment of neuroinflammatory diseases such as multiple sclerosis.
Over the last decade, one of the major challenges faced by pharmaceutical companies across the globe is low drug solubility. In fact, it has been observed that around 40% of the pharmaceutical drugs approved by regulatory organizations exhibit poor bioavailability / solubility.
AMR and multi-drug resistance are said to result in the deaths of more than five million people per year. Nine universities and research institutes, along with seven medical and industry partners, will work on the IN-ARMOR project across nine EU countries.
Nanoscale machinery has many uses, including drugdelivery, single-atom transistor technology, or memory storage. However, the machinery must be assembled at the nanoscale which is a considerable challenge for researchers.
Collaboration of researchers will improve imaging methods to assess extent of drugdelivery to the skin – including creams and lotions for conditions like eczema
Global Transdermal DrugDelivery Systems Market Research Report 2021: Industry Trends, Share, Size, Growth, Opportunity and Forecasts, 2015-2020 & 2021-2026 – ResearchAndMarkets.com Global Transdermal DrugDelivery Systems Market Research Report 2021: Industry Trends, Share, Size, Growth, Opportunity and Forecasts, 2015-2020 … Continue (..)
Dill/NIST In a technique known as DNA origami, researchers fold long strands of DNA over and over again to construct a variety of tiny 3D structures, including miniature biosensors and drug-delivery containers.
Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Nanosyrinx raises £6.2m to validate drugdelivery platform. from European Biotechnology – first and foremost in European biotech [link].
The 2024 ASCO Annual Meeting from the American Society of Clinical Oncology is a fantastic platform for clinical researchers to discuss the latest advancements and challenges in oncology research. Currently, there are 12 approved ADC drugs, and several hundred more are in the development pipeline.
In a significant move set to reshape the landscape of drug discovery, NovAliX, a leading Contract Research Organization (CRO) specializing in drug development, has entered a strategic partnership with Bruker, a global leader in scientific instruments.
KBI Biopharma, Veranova and Kindeva DrugDelivery are among the companies welcoming new faces to top jobs. Bio Pharma Reporter and Outsourcing Pharma is back with our latest instalment of movers and shakers - breaking down all the key pharma industry appointments that you should know about.
Ceapro has extended a partnership underway to carry out a further research project with McMaster University for developing an inhalable immuno-therapeutic/-prophylactic for Covid-19-induced lung fibrosis. This project is intended to develop therapies for people suffering from Covid-19’s long-term effects.
Owing to their unique size and physicochemical properties ( surface roughness, surface area, surface energy, crystal structure and shape ), nanoparticles can be widely used as a contrasting agent in medical imaging, a vesicle to cross the blood-brain barrier and a carrier for targeted delivery of genes / drugs, proteins, vaccines and antibiotics.
RVAC Medicines has signed a master research partnership agreement with the Agency for Science, Technology and Research (A*STAR) for analysing and developing solutions to build messenger ribonucleic acid (mRNA) manufacturing and analytics expertise in Singapore.
Researchers at ETH Zurich have developed a method for concentrating and releasing drugs in the brain with pinpoint accuracy. This could make it possible in the future to deliver psychiatric and cancer drugs and other medications only to those regions of the brain where this is medically desirable.
We organize all of the trending information in your field so you don't have to. Join 21,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content